Journal of Alzheimers Disease & Parkinsonism
Open Access

Abstract

Stroke and arteriosclerosis with neurological consequences such as Alzheimer disease (AD) are two leading causes of ageassociated disability, dementia, and death. AD is now the sixth-leading cause of death in the United States. In the US, AD is estimated to affect 4 million people (rising steeply from <1% of the population aged 65 to 40% of those aged 90) and costs $600 billion per year, which is equivalent to the total cost of stroke, heart disease, and cancer combined. Overall, there are no effective strategies for determining and controlling this devastating disease. Because AD is a multifactorial pathology and the development of new multitarget neuroprotective drugs is promising and attractive.

Biography